Characterization of cytochrome P450 protein expression along the entire length of the intestine of male and female rats

D Mitschke, A Reichel, G Fricker, U Moenning - Drug Metabolism and …, 2008 - ASPET
Intestinal cytochrome P450 (P450) proteins play an important role in the biotransformation
of drugs and may significantly limit their oral absorption and bioavailability. Therefore, we …

[HTML][HTML] Characterization of the Menin-MLL interaction as therapeutic cancer target

…, U Eberspaecher, ND Werbeck, U Moenning… - Cancers, 2020 - mdpi.com
Inhibiting the interaction of menin with the histone methyltransferase MLL1 (KMT2A) has
recently emerged as a novel therapeutic strategy. Beneficial therapeutic effects have been …

CCR1 is an early and specific marker of Alzheimer's disease

…, V Haroutunian, U Moenning… - Annals of Neurology …, 2003 - Wiley Online Library
Chemokines are a diverse group of small proteins that effect cell signaling by binding to G‐protein–coupled,
seven‐trans‐membrane receptors. Our group had found previously that the …

N-glycosylation of ABC transporters is associated with functional activity in sandwich-cultured rat hepatocytes

…, A Reichel, W Weitschies, U Moenning - European journal of …, 2010 - Elsevier
Hepatobiliary elimination via canalicular efflux transport proteins plays a key role in the
clearance of endo- and xenobiotics. Correct membrane localization and coordinated action of the …

Development of a fluorescence-based assay for drug interactions with human Multidrug Resistance Related Protein (MRP2; ABCC2) in MDCKII-MRP2 membrane …

C Lechner, V Reichel, U Moenning, A Reichel… - European Journal of …, 2010 - Elsevier
PURPOSE: To establish a fluorescence-based assay for drug interactions with the ABC-export-protein
MRP2 (ABCC2). METHODS: Apical membrane vesicles were isolated by …

Preclinical activity of the first reversible, potent and selective inhibitor of EGFR exon 20 insertions

…, U Boemer, U Eberspaecher, D Korr, U Moenning… - Cancer Research, 2021 - AACR
Several targeted therapeutic options exist for non-small cell lung cancer (NSCLC) patients
whose tumors harbor mutations of EGFR, including L858R, exon 19 deletions, and the …

Progress in the identification of stroke-related genes: emerging new possibilities to develop concepts in stroke therapy

A Lippoldt, A Reichet, U Moenning - Cns Drugs, 2005 - Springer
Stroke is a very complex disease influenced by many risk factors: genetic, environmental and
comorbidities, such as hypertension, diabetes mellitus, obesity and having had a previous …

BAY 1082439, a highly selective and balanced PI3Kα/β inhibitor demonstrated potent activity in tumors with activated PI3Kα and loss-of-function of PTEN

N Liu, WJ Scott, A Haegebarth, U Moenning, R Fricke… - Cancer Research, 2012 - AACR
The PI3K pathway plays critical roles in cancer cell growth and survival, as well as in intrinsic
and acquired resistance to both chemotherapy and targeted agents. These essential roles …

How to develop ACC1 inhibitors targeting lipid metabolism and oncogenic signaling pathways effectively and safely

…, K Doddapuneni, J Yaligar, KT Thede, U Moenning… - Cancer Research, 2015 - AACR
Although targeting lipogenesis for cancer treatment appears to have a strong rationale, drug
discovery in this field has not been fully explored due to the lack of understanding the mode …

High target binding affinity with long lasting cellular target engagement and high dose intermittent schedule of PI3K inhibitor copanlisib contribute to the potent anti …

…, S Glaeske, V Puetter, MB Robers, U Moenning… - Cancer Research, 2017 - AACR
Introduction: Several generations of PI3K inhibitors have been tested in clinic. However,
thus far, clinical activity has been moderate. Different from other oral PI3K inhibitors dosed …